LeMaitre Vascular Inc (LMAT)
Liquidity ratios
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current ratio | 13.14 | 7.74 | 8.09 | 7.34 | 6.32 | 6.28 | 6.75 | 6.89 | 6.39 | 6.53 | 6.34 | 7.74 | 6.41 | 6.06 | 4.19 | 4.07 | 3.75 | 2.30 | 2.07 | 5.41 |
| Quick ratio | 9.79 | 4.22 | 4.44 | 4.04 | 3.52 | 3.34 | 3.49 | 3.39 | 3.26 | 3.40 | 3.23 | 3.88 | 3.21 | 3.03 | 1.01 | 1.06 | 1.07 | 0.77 | 0.56 | 1.85 |
| Cash ratio | 9.79 | 4.22 | 4.44 | 4.04 | 3.52 | 3.34 | 3.49 | 3.39 | 3.26 | 3.40 | 3.23 | 3.88 | 3.21 | 3.03 | 1.01 | 1.06 | 1.07 | 0.77 | 0.56 | 1.85 |
LeMaitre Vascular Inc's current ratio has shown a relatively stable and strong performance over the periods analyzed. It increased from 5.41 on March 31, 2020, to a peak of 13.14 on December 31, 2024. This indicates that the company had more than enough current assets to cover its current liabilities during the most recent period. A current ratio above 1 suggests good short-term financial health, and LeMaitre Vascular Inc consistently maintained this above 1 throughout the analyzed periods.
The quick ratio, which provides a more stringent measure of liquidity by excluding inventory from current assets, also displayed a positive trend. It climbed from 1.85 on March 31, 2020, to 9.79 on December 31, 2024. This suggests that the company had a strong ability to meet its short-term obligations without relying on inventory holdings.
Similarly, the cash ratio, which is the most stringent liquidity measure as it only considers cash and cash equivalents, exhibited a robust performance. It followed a similar upward trajectory to the quick ratio, reaching 9.79 on December 31, 2024. This indicates that LeMaitre Vascular Inc had a healthy level of cash reserves to cover its immediate liabilities and demonstrates strong liquidity management.
Overall, based on the liquidity ratios analyzed, LeMaitre Vascular Inc seems to have maintained a solid liquidity position over the periods examined, with a strong ability to meet its short-term obligations using various levels of current assets and cash reserves.
Additional liquidity measure
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash conversion cycle | days | 289.90 | 337.05 | 298.13 | 290.18 | 281.22 | 312.07 | 311.49 | 330.75 | 323.30 | 314.33 | 313.49 | 312.19 | 317.26 | 307.35 | 309.06 | 351.79 | 367.99 | 397.91 | 456.08 | 385.40 |
The cash conversion cycle of LeMaitre Vascular Inc has shown fluctuations over the past few years. From March 31, 2020, to June 30, 2022, the company's cash conversion cycle ranged from 309.06 days to 456.08 days. The highest cash conversion cycle was noted on June 30, 2020, indicating a longer period to convert its inventory and receivables into cash, which could potentially signal inefficiencies in managing working capital.
However, from December 31, 2023, to December 31, 2024, the trend showed an improvement, with the cash conversion cycle decreasing from 281.22 days to 289.90 days. This could suggest that the company has become more effective in managing its working capital, resulting in a shorter time to convert its resources into cash.
Overall, it is essential for LeMaitre Vascular Inc to consistently monitor and optimize its cash conversion cycle to ensure efficient use of resources and maintain a healthy cash flow position.